메뉴 건너뛰기




Volumn 34, Issue 3, 2001, Pages 435-440

Hepatitis C viral kinetics in difficult to treat patients receiving high dose interferon and ribavirin

Author keywords

Biological; Chronic; Hepatitis C; Interferon alpha ribavirin; Kinetics; Models; Treatment failure

Indexed keywords

INTERFERON; RIBAVIRIN;

EID: 0035074416     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)00033-7     Document Type: Article
Times cited : (28)

References (12)
  • 9
    • 0032585237 scopus 로고    scopus 로고
    • Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
    • International Hepatitis Interventional Therapy Group
    • (1998) Lancet , vol.352 , pp. 1426-1432
    • Poynard, T.1    Marcellin, P.2    Lee, S.S.3    Niederau, C.4    Minuk, G.S.5    Ideo, G.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.